5,6-二氢-5-氮杂胞苷用于广泛期、未经治疗的非小细胞肺癌的II期研究。 - Suppr

Phase II study of 5,6-dihydro-5-azacytidine in extensive, untreated non-small cell lung cancer.

Holoye P Y, Dhingra H M, Umsawasdi T, Murphy W K, Carr D T, Lee J S

Cancer Treat Rep. 1987 Sep;71(9):859-60.

Abstract

摘要

Cancer Treat Rep. 1987 Sep;71(9):859-60.

Cancer Res. 1987 Aug 1;47(15):4199-201.

Invest New Drugs. 1991 Feb;9(1):69-72. doi: 10.1007/BF00194548.

Cancer. 1998 Apr 15;82(8):1578-84.

South Med J. 2007 Oct;100(10):1056-7. doi: 10.1097/SMJ.0b013e318153f439.

Cancer Treat Rep. 1987 Sep;71(9):861-2.

Anticancer Drugs. 2001 Jul;12 Suppl 3:S21-T5.

Cancer Treat Rep. 1987 Nov;71(11):1097-8.

Gan To Kagaku Ryoho. 1986 Oct;13(10):2970-3.

Cancer Treat Rep. 1987 Nov;71(11):1099-100.

Invest New Drugs. 1991 Feb;9(1):69-72. doi: 10.1007/BF00194548.

20分钟写一篇综述，助力文献阅读效率提升50倍。

大模型驱动的PubMed中文搜索引擎

学术文献翻译模型，支持多种主流文档格式。